Table of Content

1 Industrial Chain Overview

• 1.1 Rare Disease Drug Industry
  • 1.1.1 Overview
  • 1.1.2 Characteristics of Rare Disease Drug
• 1.2 Upstream
  • 1.2.1 Major Materials
  • 1.2.2 Manufacturing Overview
• 1.3 Product List By Type
  • 1.3.1 >1
  • 1.3.2 0.65 1
  • 1.3.3 <0.1
• 1.4 End-Use List
  • 1.4.1 Demand in Hospital Pharmacies
  • 1.4.2 Demand in Speciality Pharmacies
  • 1.4.3 Demand in Retail pharmacies
  • 1.4.4 Demand in Others
• 1.5 Global Market Overview
  • 1.5.1 Global Market Size and Forecast, 2015-2025
  • 1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
  • 1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
  • 1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025

2 Global Production & Consumption by Geography

• 2.1 Global Production & Consumption
  • 2.1.1 Global Production
  • 2.1.2 Global Consumption
• 2.2 Geographic Production & Consumption
  • 2.2.1 Production
    • 2.2.1.1 Asia-Pacific
    • 2.2.1.2 North America
    • 2.2.1.3 South America
    • 2.2.1.4 Europe
    • 2.2.1.5 Middle East & Africa
  • 2.2.2 Consumption
    • 2.2.2.1 Asia-Pacific
    • 2.2.2.2 North America
    • 2.2.2.3 South America
    • 2.2.2.4 Europe
    • 2.2.2.5 Middle East & Africa

  3 Major Manufacturers Introduction

  • 3.1 Manufacturers Overview
  • 3.2 Manufacturers List
    • 3.2.1 Novartis AG Overview
      • 3.2.1.1 Product Specifications
      • 3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.1.3 Recent Developments
      • 3.2.1.4 Future Strategic Planning
    • 3.2.2 Bristol-Myers Squibb Company Overview
      • 3.2.2.1 Product Specifications
      • 3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.2.3 Recent Developments
      • 3.2.2.4 Future Strategic Planning
    • 3.2.3 Celgene Corporation Overview
      • 3.2.3.1 Product Specifications
      • 3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.3.3 Recent Developments
      • 3.2.3.4 Future Strategic Planning
    • 3.2.4 F. Hoffmann-La Roche Ltd. Overview
      • 3.2.4.1 Product Specifications
      • 3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.4.3 Recent Developments
      • 3.2.4.4 Future Strategic Planning
    • 3.2.5 Pfizer, Inc. Overview
      • 3.2.5.1 Product Specifications
      • 3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.5.3 Recent Developments
      • 3.2.5.4 Future Strategic Planning
    • 3.2.6 Sanofi S.A. Overview
      • 3.2.6.1 Product Specifications
      • 3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.6.3 Recent Developments
      • 3.2.6.4 Future Strategic Planning
    • 3.2.7 Alexion Pharmaceuticals, Inc. Overview
      • 3.2.7.1 Product Specifications
      • 3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.7.3 Recent Developments
      • 3.2.7.4 Future Strategic Planning
    • 3.2.8 Eli Lilly and Company Overview
      • 3.2.8.1 Product Specifications
      • 3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.8.3 Recent Developments
      • 3.2.8.4 Future Strategic Planning
    • 3.2.9 Novo Nordisk A/S Overview
      • 3.2.9.1 Product Specifications
      • 3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.9.3 Recent Developments
      • 3.2.9.4 Future Strategic Planning
    • 3.2.10 AstraZeneca Overview
      • 3.2.10.1 Product Specifications
      • 3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.10.3 Recent Developments
      • 3.2.10.4 Future Strategic Planning
    • 3.2.11 Eisai Co., Ltd. Overview
      • 3.2.11.1 Product Specifications
      • 3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.11.3 Recent Developments
      • 3.2.11.4 Future Strategic Planning
    • 3.2.12 Daiichi Sankyo Company Limited Overview
      • 3.2.12.1 Product Specifications
      • 3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.12.3 Recent Developments
      • 3.2.12.4 Future Strategic Planning
    • 3.2.13 Bayer AG Overview
      • 3.2.13.1 Product Specifications
      • 3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.13.3 Recent Developments
      • 3.2.13.4 Future Strategic Planning
    • 3.2.14 GlaxoSmithKline Overview
      • 3.2.14.1 Product Specifications
      • 3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.14.3 Recent Developments
      • 3.2.14.4 Future Strategic Planning
    • 3.2.15 Merck & Co., Inc. Overview
      • 3.2.15.1 Product Specifications
      • 3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.15.3 Recent Developments
      • 3.2.15.4 Future Strategic Planning
    • 3.2.16 Johnson & Johnson Overview
      • 3.2.16.1 Product Specifications
      • 3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.16.3 Recent Developments
      • 3.2.16.4 Future Strategic Planning
    • 3.2.17 Biogen, Inc. Overview
      • 3.2.17.1 Product Specifications
      • 3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.17.3 Recent Developments
      • 3.2.17.4 Future Strategic Planning
    • 3.2.18 Shire Overview
      • 3.2.18.1 Product Specifications
      • 3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.18.3 Recent Developments
      • 3.2.18.4 Future Strategic Planning
    • 3.2.19 Amgen, Inc. Overview
      • 3.2.19.1 Product Specifications
      • 3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.19.3 Recent Developments
      • 3.2.19.4 Future Strategic Planning
    • 3.2.20 Deciphera Overview
      • 3.2.20.1 Product Specifications
      • 3.2.20.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.20.3 Recent Developments
      • 3.2.20.4 Future Strategic Planning
    • 3.2.21 Atara Biotherapeutics Overview
      • 3.2.21.1 Product Specifications
      • 3.2.21.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.21.3 Recent Developments
      • 3.2.21.4 Future Strategic Planning
    • 3.2.22 ProQR Overview
      • 3.2.22.1 Product Specifications
      • 3.2.22.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.22.3 Recent Developments
      • 3.2.22.4 Future Strategic Planning

    4 Market Competition Pattern

    • 4.1 Market Size and Sketch
    • 4.2 Company Market Share
      • 4.2.1 Global Production by Major Manufacturers
      • 4.2.2 Market Concentration Analysis
    • 4.3 Market News and Trend
      • 4.3.1 Merger & Acquisition
      • 4.3.2 New Product Launch

    5 Product Type Segment

    • 5.1 Global Overview by Product Type Segment
    • 5.2 Segment Subdivision by Product Type
      • 5.2.1 Market in >1
        • 5.2.1.1 Market Size
        • 5.2.1.2 Situation & Development
      • 5.2.2 Market in 0.65 1
        • 5.2.2.1 Market Size
        • 5.2.2.2 Situation & Development
      • 5.2.3 Market in <0.1
        • 5.2.3.1 Market Size
        • 5.2.3.2 Situation & Development

      6 End-Use Segment

      • 6.1 Global Overview by End-Use Segment
      • 6.2 Segment Subdivision
        • 6.2.1 Market in Hospital Pharmacies
          • 6.2.1.1 Market Size
          • 6.2.1.2 Situation & Development
        • 6.2.2 Market in Speciality Pharmacies
          • 6.2.2.1 Market Size
          • 6.2.2.2 Situation & Development
        • 6.2.3 Market in Retail pharmacies
          • 6.2.3.1 Market Size
          • 6.2.3.2 Situation & Development
        • 6.2.4 Market in Others
          • 6.2.4.1 Market Size
          • 6.2.4.2 Situation & Development

        7 Market Forecast & Trend

        • 7.1 Regional Forecast
        • 7.2 Consumption Forecast
          • 7.2.1 Product Type Forecast
          • 7.2.2 End-Use Forecast
        • 7.3 Investment Trend
        • 7.4 Consumption Trend

        8 Price & Channel

        • 8.1 Price and Cost
          • 8.1.1 Price
          • 8.1.2 Cost
        • 8.2 Channel Segment

        9 Market Drivers & Investment Environment

        • 9.1 Market Drivers
        • 9.2 Investment Environment

        10 Research Conclusion

        List of Tables

        Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025

        Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025

        Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025

        Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume

        Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD

        Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume

        Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD

        Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Major Manufacturers Headquarters and Contact Information

        Table Major Manufacturers Capacity List in 2018

        Table Novartis AG Overview List

        Table Rare Disease Drug Business Operation of Novartis AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Bristol-Myers Squibb Company Overview List

        Table Rare Disease Drug Business Operation of Bristol-Myers Squibb Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Celgene Corporation Overview List

        Table Rare Disease Drug Business Operation of Celgene Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table F. Hoffmann-La Roche Ltd. Overview List

        Table Rare Disease Drug Business Operation of F. Hoffmann-La Roche Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Pfizer, Inc. Overview List

        Table Rare Disease Drug Business Operation of Pfizer, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Sanofi S.A. Overview List

        Table Rare Disease Drug Business Operation of Sanofi S.A. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Alexion Pharmaceuticals, Inc. Overview List

        Table Rare Disease Drug Business Operation of Alexion Pharmaceuticals, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Eli Lilly and Company Overview List

        Table Rare Disease Drug Business Operation of Eli Lilly and Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Novo Nordisk A/S Overview List

        Table Rare Disease Drug Business Operation of Novo Nordisk A/S (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table AstraZeneca Overview List

        Table Rare Disease Drug Business Operation of AstraZeneca (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Eisai Co., Ltd. Overview List

        Table Rare Disease Drug Business Operation of Eisai Co., Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Daiichi Sankyo Company Limited Overview List

        Table Rare Disease Drug Business Operation of Daiichi Sankyo Company Limited (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Bayer AG Overview List

        Table Rare Disease Drug Business Operation of Bayer AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table GlaxoSmithKline Overview List

        Table Rare Disease Drug Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Merck & Co., Inc. Overview List

        Table Rare Disease Drug Business Operation of Merck & Co., Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Johnson & Johnson Overview List

        Table Rare Disease Drug Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Biogen, Inc. Overview List

        Table Rare Disease Drug Business Operation of Biogen, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Shire Overview List

        Table Rare Disease Drug Business Operation of Shire (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Amgen, Inc. Overview List

        Table Rare Disease Drug Business Operation of Amgen, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Deciphera Overview List

        Table Rare Disease Drug Business Operation of Deciphera (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Atara Biotherapeutics Overview List

        Table Rare Disease Drug Business Operation of Atara Biotherapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table ProQR Overview List

        Table Rare Disease Drug Business Operation of ProQR (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Global Production Volume List by Manufacturers, 2015-2018, in Volume

        Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume

        Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD

        Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume

        Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume

        Table Global Market Forecast by Region Segment 2019-2025, in Million USD

        Table Global Market Forecast by Region Segment 2019-2025, in Volume

        Table Global Market Amount by Product Type Segment 2019-2025, in Million USD

        Table Global Market Volume by Product Type Segment 2019-2025, in Volume

        Table Global Market Amount by End-Use Segment 2019-2025, in Million USD

        Table Global Market Volume by End-Use Segment 2019-2025, in Volume

        List of Figures

        Figure Rare Disease Drug Picture List

        Figure Global Market Size and Forecast with Growth Rate, 2015-2025

        Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Global Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure North America Market Volume and Growth Rate, 2015-2018, in Volume

        Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

        Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Global Production Volume Share by Manufacturers in 2019, in Volume

        Figure Global Production Amount Share by Manufacturers in 2019, in Million USD

        Figure Global Market Amount and Growth Rate in >1, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in >1, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in 0.65 1, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in 0.65 1, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in <0.1, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in <0.1, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Hospital Pharmacies, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Hospital Pharmacies, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Speciality Pharmacies, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Speciality Pharmacies, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Retail pharmacies, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Retail pharmacies, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume

According to 99Strategy, the Global Rare Disease Drug Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Rare Disease Drug market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
Novartis AG
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Sanofi S.A.
Alexion Pharmaceuticals, Inc.
Eli Lilly and Company
Novo Nordisk A/S
AstraZeneca
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
GlaxoSmithKline
Merck & Co., Inc.
Johnson & Johnson
Biogen, Inc.
Shire
Amgen, Inc.
Deciphera
Atara Biotherapeutics
ProQR
Key Product Type
>1
0.65 1
<0.1
Market by Application
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
Main Aspects covered in the Report
Overview of the Rare Disease Drug market including production, consumption, status & forecast and market growth
2015-2018 historical data and 2019-2025 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development